Clinical Trials Browser

Neoplasms × denileukin diftitox × Clear all

NCT01127451 2022-04-13

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Phase 2 Completed

75 enrolled 15 charts

Melanoma, Neoplasms

NCT01432483 2015-01-26

Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

No longer available

Neoplasms, Recurrence